EGFR regulates the side population in head and neck squamous cell carcinoma.
about
Side population cells as prototype of chemoresistant, tumor-initiating cellsLung cancer stem cells and low-intensity laser irradiation: a potential future therapy?ATP-binding cassette G-subfamily transporter 2 regulates cell cycle progression and asymmetric division in mouse cardiac side population progenitor cells.Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signallingRecent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapiesA new gamboge derivative compound 2 inhibits cancer stem-like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma.New promising drug targets in cancer- and metastasis-initiating cells.Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.Ionizing radiation induces stemness in cancer cellsIsolation and genomic characterization of stem cells in head and neck cancer.Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cellsRecent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Activity of ABCG2 Is Regulated by Its Expression and Localization in DHT and Cyclopamine-Treated Breast Cancer Cells.Head and Neck Cancer Stem Cells: From Identification to Tumor Immune NetworkPutative cancer stem cells in cutaneous malignancies.Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/PgpCancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.A quest for initiating cells of head and neck cancer and their treatment.ABCG2: the key to chemoresistance in cancer stem cells?Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.MC3 Mucoepidermoid carcinoma cell line enriched cancer stem-like cells following chemotherapy.Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.Human ABCG2: structure, function, and its role in multidrug resistance.Cancer stem cells in human digestive tract malignancies.Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro.Dormancy activation mechanism of oral cavity cancer stem cells.Fluorouracil selectively enriches stem-like cells in the lung adenocarcinoma cell line SPC.EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.Optimization of Storage Temperature for Retention of Undifferentiated Cell Character of Cultured Human Epidermal Cell Sheets.NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells.
P2860
Q26823433-32146499-E5E5-4D03-9E63-4B9B1D16BFE4Q27021829-9A6DFD5E-166D-449E-A9DE-69534C726CB0Q30574363-990DE385-4F67-47E3-A596-2A7561EF24C0Q33708119-CF4CB2B5-9B4A-4CCA-8A09-159246EEFAC1Q33730375-20F89E03-E18C-447B-B20B-7E299417BF34Q33982339-28AE4D63-B1EE-4191-B1CC-EB371B0B33B1Q34003691-838D67C9-8C6E-4067-BA3B-6557F7E2EDC4Q34244929-2D9058B6-9DE2-4A88-8E24-2CBA1776D3C0Q34382586-0A45F6FD-FBB4-4A6C-BB46-6713CFC20303Q34395869-99F4BA80-32FC-46B0-9DD1-FE0A56EAE83EQ34459980-EF6010C3-411A-49F9-A2AA-5E07E76198B8Q34472249-4842F9E3-BDCE-4BBE-B61E-B32D4FB717ABQ35214554-2AD4F354-E0F4-4A29-BD72-309E53A818B5Q35459525-D606BF63-1C23-4484-B81F-21F0C5FDE4C8Q35936477-9A2A96BF-FD51-4A3F-97D1-CB06AC7AF646Q36212296-BEFB8938-F7A3-4CB8-890F-B02BC15197D8Q36759571-3BBC68C0-1D3A-47E2-A45B-9A88ADA9A62FQ37021815-1991807A-766A-47F5-8FBF-DF3E1F3F3852Q37316834-37C946B3-A862-472B-AF36-46D0180895F4Q37334258-6416E74C-8D08-43D2-92BB-400FC4FFEFDBQ37587219-B28A33BC-7524-4D30-81C7-1CF634F70A75Q37610799-1BA0F7FD-22DE-48D4-87AC-6F128FFBD386Q37706017-8604A87F-9DAA-4603-B46E-C2A5B4944103Q37720052-9CA055D4-1AE0-4CE2-807E-DC88C565A7B2Q37958162-F71646D6-EF1C-41D5-9460-9817BB0E7A3EQ38003156-56DE4563-D090-426E-A06E-61A9B7B6A2F2Q38601789-1D504F20-5639-4D4E-A98E-F55075CC0116Q38704919-D5AF6031-A15C-40D0-A4B2-C7CC24EC4998Q38905567-42B4D017-66F2-4AE5-8365-92810CC6A5C3Q39202792-05FE43C7-D7CA-4472-8FCC-10761A6396C6Q39270164-212E5964-56A7-4D84-8A01-F0CD2614EF6BQ39300015-18FAB95B-75D7-4439-9951-58EF4A67505FQ41420148-84063965-5F5E-45A8-ADF2-2856859146E1Q47111415-02075CB0-1079-4057-B7BE-C4E266FF147B
P2860
EGFR regulates the side population in head and neck squamous cell carcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
EGFR regulates the side population in head and neck squamous cell carcinoma.
@ast
EGFR regulates the side population in head and neck squamous cell carcinoma.
@en
type
label
EGFR regulates the side population in head and neck squamous cell carcinoma.
@ast
EGFR regulates the side population in head and neck squamous cell carcinoma.
@en
prefLabel
EGFR regulates the side population in head and neck squamous cell carcinoma.
@ast
EGFR regulates the side population in head and neck squamous cell carcinoma.
@en
P2093
P1433
P1476
EGFR regulates the side population in head and neck squamous cell carcinoma.
@en
P2093
Francisco S Pardo
Jocelyn S Chen
Joseph Aguilera
Robert A Weisman
Theresa S Chu
Weg M Ongkeko
Xabier Altuna
P304
P356
10.1097/01.MLG.0000195075.14093.FB
P407
P577
2006-03-01T00:00:00Z